Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anna Sztafińska
Omalizumab in the Prevention of Anaphylaxis During Immunotherapy: A
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
Related publications
Off-Label Use of Omalizumab in Pediatric Anaphylaxis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Predictors of Allergic Symptoms and Anaphylaxis During Peanut Oral Immunotherapy
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Anaphylaxis During Specific Subcutaneous Immunotherapy Against Ragweed Allergen -- Case Record
Clinical and Translational Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
The Risk and Management of Anaphylaxis in the Setting of Immunotherapy
American Journal of Rhinology and Allergy
Medicine
Otorhinolaryngology
Allergy
Immunology
Alternative Dosing of Omalizumab as an Adjunct Therapy During Multiallergen Oral Immunotherapy in Food Allergic Patients
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Immunotherapy for Mouse Bite Anaphylaxis and Allergy
Annals of Allergy, Asthma and Immunology
Respiratory Medicine
Pulmonary
Allergy
Immunology
Omalizumab: A Useful Tool for Inducing Tolerance to Bee Venom Immunotherapy
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
Being “SCIT” Careful in the Spring: Analyzing Patterns of Immunotherapy-Induced Anaphylaxis Over the Years
Journal of Allergy and Clinical Immunology
Allergy
Immunology
PVX108 Peptide Immunotherapy Significantly Reduces Markers of Peanut-Induced Anaphylaxis in a Dose-Dependent Manner
Journal of Allergy and Clinical Immunology
Allergy
Immunology